Document is current

Any future updates will be listed below

Long-term outcome of a phase II trial using immunomodulatory in situ gene therapy in combination with intensity-modulated radiotherapy with or without hormonal therapy in the treatment of prostate cancer

Crossref DOI link: https://doi.org/10.1007/s13566-015-0239-y

Published Online: 2015-12-12

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark